Vanillyl Alcohol

Vanillyl Alcohol

SCHEMBL118233

CC(C)OC(C)C.COc1cc(CO)ccc1O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOS P01100 1/20 0.63
TTR P02766 1/20 0.63
JUN P05412 1/20 0.63
NR3C1 P04150 1/20 0.63
HSD17B1 P14061 1/20 0.63
HSD17B2 P37059 1/20 0.63
CYP3A4 P08684 3/20 0.59
MMP1 P03956 1/20 0.59
ALOX15 P16050 2/20 0.58
ALOX12 P18054 2/20 0.58
TSHR P16473 3/20 0.56
TAAR1 Q96RJ0 2/20 0.56
MAPK1 P28482 1/20 0.56
LMNA P02545 1/20 0.54
GLA P06280 1/20 0.54
ALDH1A1 P00352 2/20 0.53
ALOX5 P09917 2/20 0.53
GAA P10253 1/20 0.53
NFKB1 P19838 1/20 0.53
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vanillyl Alcohol SCHEMBL27774687 0.89 TAAR1 (0.67) FOSTTRJUNNR3C1HSD17B1
Vanillyl Alcohol SCHEMBL29408335 0.89 TAAR1 (0.67) FOSTTRJUNNR3C1HSD17B1
Vanillyl Alcohol SCHEMBL62348 0.89 TAAR1 (0.67) FOSTTRJUNNR3C1HSD17B1
Vanillyl Alcohol SCHEMBL116860 0.88 TAAR1 (0.65) FOSTTRJUNNR3C1HSD17B1
Vanillyl Alcohol SCHEMBL2238547 0.86 TAAR1 (0.62) FOSTTRJUNNR3C1HSD17B1
Vanillyl Alcohol SCHEMBL28311546 0.84 FOS (0.47) FOSTTRJUNNR3C1HSD17B1
Vanillyl Alcohol SCHEMBL116331 0.84 FOS (0.59) FOSTTRJUNNR3C1HSD17B1
Vanillyl Alcohol SCHEMBL580130 0.81 FOS (0.56) FOSTTRJUNNR3C1HSD17B1
Vanillyl Alcohol SCHEMBL579759 0.81 TAAR1 (0.57) FOSTTRJUNNR3C1HSD17B1
Vanillyl Alcohol SCHEMBL29092590 0.81 TAAR1 (0.57) FOSTTRJUNNR3C1HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1047 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115721567-A Thermal wet tissue and preparation method thereof 芜湖悠派护理用品科技股份有限公司 2023-03-03 CN claimed
CN-113389055-A Cool or heat-sensitive microcapsule, nonwoven fabric and absorbent article 上海护理佳实业有限公司 2021-09-14 CN claimed
US-20210212983-A1 ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS CHICAGO ATLANTIC ADMIN, LLC 2021-07-15 US claimed
CN-111962292-A Spontaneous heating material body and spontaneous heating activated carbon non-woven fabric hair cap 上海创始实业(集团)有限公司 2020-11-20 CN claimed
EP-2742983-B1 Method for isolating fragrance and flavour compounds SYMRISE AG (DE) 2017-08-23 EP claimed
EP-1924148-B1 CONFECTIONERY COMPOSITION INCLUDING AN ELASTOMERIC COMPONENT, A COOKED SACCHARIDE COMPONENT, AND A SENSATE INTERCONTINENTAL GREAT BRANDS LLC (US) 2016-07-20 EP claimed
US-20160198747-A1 1H-PYRROLE-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS IMAX DISCOVERY GMBH (DE) 2016-07-14 US claimed
EP-3041370-A1 1H-PYRROLE-2,4-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS IMAX Discovery GmbH (DE) 2016-07-13 EP claimed
CN-105473002-A 1H-PYRROLE-2,4-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS FRESENIUS KABI DE GMBH 2016-04-06 CN claimed
CN-103006509-B Emulsion compositions and apply its wet tissue GOLD HONG YE PAPER Co.,Ltd. (CN) 2016-03-02 CN claimed
EP-0977554-B1 CONFECTIONERY COMPOSITIONS PROCTER & GAMBLE (US) 2004-06-16 EP claimed
EP-0977553-B1 THROAT SOOTHING COMPOSITIONS PROCTER & GAMBLE (US) 2003-09-10 EP claimed
US-6432441-B1 ENCAPSULATION OF ANALGESICS, EXPECTORANTS OR ANTITUSSIVE AGENTS WITHIN PHOSPHATIDES TO PROLONG DRUG DELIVERY THE PROCTER & GAMBLE COMPANY 2002-08-13 US claimed
US-6306429-B1 THROAT DROPS SUITABLE FOR RELIEF OF COUGH AND COLD SYMPTOMS THE PROCTER & GAMBLE COMPANY 2001-10-23 US claimed
EP-0977554-A1 CONFECTIONERY COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-02-09 EP claimed
EP-0977553-A1 THROAT SOOTHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-02-09 EP claimed
WO-1998047483-A1 CONFECTIONERY COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO claimed
WO-1998047482-A1 THROAT SOOTHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO claimed
EP-0837862-A1 WARMING COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1998-04-29 EP claimed
WO-1997002273-A1 WARMING COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1997-01-23 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210212983-A1 ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS CNR2, CNR1, CPNE4 FOS 306/4885TTR 4386/4885JUN 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.